Frontlight ResearchEarly access
Trial site
Jiangsu Province Hospital of Chinese Medicine
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease2 trials
- Crohn's disease2 trials
- Ulcerative colitis2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Peripheral artery disease1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed4 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Hoffmann-La Roche2 trials
- Bayer1 trial
- CSL Behring1 trial
- First Hospital of China Medical University1 trial
- and 4 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic kidney disease1 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Peripheral artery disease1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026